Amino Acid Kinetics in Blood After Consuming Different Milk Protein Supplements

NCT ID: NCT02882386

Last Updated: 2016-08-29

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

13 participants

Study Classification

INTERVENTIONAL

Study Start Date

2012-09-30

Study Completion Date

2013-02-28

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of this study is to investigate the amino acid kinetics in blood after a bout of strength training and ingestion of different milk protein supplements (native whey, whey protein concentrate 80, hydrolysed whey, microparticulated whey and milk) The investigators hypothesize that native whey will give a faster and higher rise in blood concentrations of leucine compared to the other milk protein supplements.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Increasing or maintaining muscle mass is of great importance for populations ranging from athletes to patients and elderly. Resistance exercise and protein ingestion are two of the most potent stimulators of muscle protein synthesis. Both the physical characteristic of proteins (e.g. different digestion rates of whey and casein) and the amino acid composition, affects the potential of a certain protein to stimulate muscle protein synthesis. Given its superior ability to rapidly increase blood leucine concentrations to high levels, whey is often considered the most potent protein source to stimulate muscle protein synthesis. Native whey protein is produced by filtration of unprocessed milk. Consequently, native whey has different characteristics than WPC-80, which is exposed to heating and acidification. Because of the direct filtration of unprocessed milk, native whey is a more intact protein compared with WPC-80. Of special interest is the higher amounts of leucine in native whey.

The aim of this double-blinded randomized 5-arm cross-over study is to compare amino acid kinetics in blood after a bout of strength training and ingestion of 20 grams of high quality, but distinct, dairy protein supplements (native whey, whey protein concentrate 80, hydrolysed whey, microparticulated whey and milk). Furthermore, the investigators investigate whether differences in amino acid kinetics affect acute blood glucose and urea response, as well as recovery of muscle function after a bout of strength training.

The investigators hypothesize that native whey will give a faster and higher rise in blood concentrations of leucine compared to the other protein supplements.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Healthy Participants

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

QUADRUPLE

Participants Caregivers Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Milk 1%

Participants performed a bout of strength training and consumed 636 ml of a protein supplement

Group Type PLACEBO_COMPARATOR

Strength Training

Intervention Type OTHER

Milk 1%

Intervention Type DIETARY_SUPPLEMENT

Whey protein concentrate 80 (WPC-80)

Participants performed a bout of strength training and consumed 636 ml of a protein supplement

Group Type EXPERIMENTAL

Strength Training

Intervention Type OTHER

Whey protein concentrate 80 (WPC-80)

Intervention Type DIETARY_SUPPLEMENT

Microparticulated whey

Participants performed a bout of strength training and consumed 636 ml of a protein supplement

Group Type EXPERIMENTAL

Strength Training

Intervention Type OTHER

Microparticulated whey

Intervention Type DIETARY_SUPPLEMENT

Hydrolyzed whey

Participants performed a bout of strength training and consumed 636 ml of a protein supplement

Group Type EXPERIMENTAL

Strength Training

Intervention Type OTHER

Hydrolyzed whey

Intervention Type DIETARY_SUPPLEMENT

Native whey

Participants performed a bout of strength training and consumed 636 ml of a protein supplement

Group Type EXPERIMENTAL

Strength Training

Intervention Type OTHER

Native whey

Intervention Type DIETARY_SUPPLEMENT

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Strength Training

Intervention Type OTHER

Milk 1%

Intervention Type DIETARY_SUPPLEMENT

Whey protein concentrate 80 (WPC-80)

Intervention Type DIETARY_SUPPLEMENT

Microparticulated whey

Intervention Type DIETARY_SUPPLEMENT

Hydrolyzed whey

Intervention Type DIETARY_SUPPLEMENT

Native whey

Intervention Type DIETARY_SUPPLEMENT

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Protein supplementation Protein supplementation Protein supplementation Protein supplementation Protein supplementation

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Healthy in the sense that they can conduct training and testing
* Able to understand Norwegian language written and oral

Exclusion Criteria

* Diseases or injuries contraindicating participation
* Use of dietary supplements (e.g. proteins, vitamins and creatine)
* Lactose intolerance
* Allergy to milk
* Allergy towards local anesthetics (xylocain)
Minimum Eligible Age

18 Years

Maximum Eligible Age

45 Years

Eligible Sex

MALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Arkansas Children's Hospital Research Institute

OTHER

Sponsor Role collaborator

Tine

INDUSTRY

Sponsor Role collaborator

Norwegian School of Sport Sciences

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Havard Hamarsland

PhD student

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Truls Raastad, PhD

Role: PRINCIPAL_INVESTIGATOR

Norwegian School of Sport Sciences

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

NorwegianSSS

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.